ecancer Managing Editor, Prof Gordon McVie, gives his overview of the news from the 2013 European Cancer Congress including:

Longest follow-up of largest number of melanoma patients treated with ipilimumab shows some survive up to ten years

Promising results for new antibody drug in non-small cell lung cancer

Diabetes increases the risk of developing and dying from breast and colon cancer

and Anti-cancer drug T-DM1 benefits women with advanced breast cancer who have failed several previous treatments: results from TH3RESA trial

свернуть